Affimed
AFMD
$5.03
Share price
3.07%
Change (1 day)
458.89%
Change (1 year)
Categories
EPS for Affimed (AFMD)
EPS in 2023 (TTM): -$0.79
According to Affimed 's latest financial reports the company's current EPS (TTM) is -$0.79. In 2022 the company made an earnings per share (EPS) of -$0.64 a decrease over its 2021 EPS that were of -$0.56.
EPS history for Affimed from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.79 | 24.27% |
| 2022 | -$0.64 | 14.29% |
| 2021 | -$0.56 | -6.12% |
| 2020 | -$0.59 | 6.12% |
| 2019 | -$0.56 | 44.87% |
| 2018 | -$0.39 | -51.19% |
| 2017 | -$0.79 | -25.98% |
| 2016 | -$1.07 | 41.08% |
| 2015 | -$0.76 | -454.63% |
| 2014 | $0.21 | -114.76% |
| 2013 | -$1.44 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $2.09 | -364.52% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | -$0.11 | -86.08% | 🇺🇸 USA |
 Agenus
AGEN | -$0.85 | 7.58% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$9.78 | 1,137.51% | 🇺🇸 USA |